🔴 Picard Medical is trading 5% down in pre-market with no clear catalyst identified

Picard Medical is trading 5.17% down at $8.99 in the October 12 pre-market, with no clear company-specific catalyst identified.

• An October 9 law-firm release publicized an investigation and allegations already made in a securities complaint; it did not attribute a share-price decline to the release.
• Sector context is positive and broad-market moves are modest; neither clearly explains the decline. Recent sessions included a sharp run-up, but that does not establish the reason for the pre-market drop.